Tumor cell recognition efficiency by T cells
- PMID: 15783261
- PMCID: PMC1069668
- DOI: 10.1371/journal.pmed.0020077
Tumor cell recognition efficiency by T cells
Conflict of interest statement
Comment on
-
Diversity and recognition efficiency of T cell responses to cancer.PLoS Med. 2004 Nov;1(2):e28. doi: 10.1371/journal.pmed.0010028. Epub 2004 Nov 30. PLoS Med. 2004. PMID: 15578105 Free PMC article. Clinical Trial.
References
-
- Men Y, Miconnet I, Valmori D, Rimoldi D, Cerottini JC, et al. Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. J Immunol. 1999;162:3566–3573. - PubMed
-
- Valmori D, Fonteneau JF, Marañón Lizana C, Gervois N, Liénard D, et al. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs. J Immunol. 1998;160:1750–1758. - PubMed
-
- Ayyoub M, Zippelius A, Pittet MJ, Rimoldi D, Valmori D, et al. Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/MART-1. Clin Cancer Res. 2003;9:669–677. - PubMed
-
- Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Lienard D, et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of local functional tolerance. Cancer Res. 2004;64:2865–2873. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
